CWA Asset Management Group’s Virtus Biotech ETF BBP Stock Holding History

CWA Asset Management Group’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Sell	18,606 -2,587	-12%	-$225K	0.05%	308
2026 Q1	$1.76M	Sell	21,193 -2,478	-10%	-$204K	0.06%	282
2025 Q4	$1.89M	Sell	23,671 -75	-0.3%	-$5.69K	0.07%	249
2025 Q3	$1.66M	Buy	23,746 +741	+3%	+$48.5K	0.06%	269
2025 Q2	$1.34M	Sell	23,005 -1,796	-7%	-$102K	0.06%	276
2025 Q1	$1.45M	Sell	24,801 -656	-3%	-$40.2K	0.07%	231
2024 Q4	$1.53M	Buy	25,457 +168	+0.7%	+$10.6K	0.08%	195
2024 Q3	$1.59M	Buy	+25,289	New	+$1.57M	0.08%	179

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CWA Asset Management Group's BBP Position: Q2 2026 in Review

CWA Asset Management Group reduced its Virtus Biotech ETF (BBP) stake by 12% in Q2 2026, selling an estimated $225K and leaving 18,606 shares worth $1.79M. The position accounts for 0.05% of the portfolio, ranked #308.

CWA Asset Management Group first reported a position in BBP in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.89M in Q4 2025. 5 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

CWA Asset Management Group held 18,606 shares of Virtus Biotech ETF worth $1.79M as of Q2 2026.
CWA Asset Management Group sold 2,587 Virtus Biotech ETF shares in Q2 2026, an estimated $225K.
Virtus Biotech ETF made up 0.05% of CWA Asset Management Group's portfolio in Q2 2026, its #308 holding.
CWA Asset Management Group first reported a position in Virtus Biotech ETF in Q3 2024 and has held it in 8 quarters since.
CWA Asset Management Group's Virtus Biotech ETF position peaked at $1.89M in Q4 2025.
5 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.